Algernon Pharmaceuticals Inc.
AGNPF
|
$0.0716
178.69%
12K
|
Health Technology
(0.0% 1d) (4.5% 1m) (-66.7% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (175.2% volume)
Earnings Calendar:
Market Cap: $ 1,549,479
http://www.algernonpharmaceuticals.com
Sec Filling | Patents | n/a employees
(CA) Algernon Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the development of repurposed therapeutic drugs. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, and idiopathic pulmonary fibrosis. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.
urea kidney diseases kidney
add to watch list Paper trade email alert is off
Press-releases
Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
AGNPF | $0.0716 178.69% 12K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
ceo pharmaceuticals
Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset
Published: 2024-04-01 (Crawled : 11:00) - globenewswire.com
AGNPF | $0.0716 178.69% 12K
|
Health Technology
|
| O: 0.37%
H: 4.5%
C: -11.69%
drug stroke pharmaceuticals research program
Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
Published: 2024-03-27 (Crawled : 16:00) - globenewswire.com
AGNPF | $0.0716 178.69% 12K
|
Health Technology
|
| O: 25.81%
H: 0.0%
C: 0.0%
acquisition pharmaceuticals research program
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD
Published: 2024-01-31 (Crawled : 12:00) - globenewswire.com
AGNPF | $0.0716 178.69% 12K
|
Health Technology
|
| O: 5.02%
H: 13.06%
C: 11.46%
patent treat pharmaceuticals grant chinese
Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis
Published: 2024-01-11 (Crawled : 12:00) - globenewswire.com
AGNPF | $0.0716 178.69% 12K
|
Health Technology
| Email alert
Add to watchlist
patent japan fibrosis pharmaceuticals
Algernon Pharmaceuticals Announces Closing of Private Placement
Published: 2023-12-27 (Crawled : 21:00) - globenewswire.com
AGNPF | $0.0716 178.69% 12K
|
Health Technology
|
| O: 9.2%
H: 20.51%
C: 15.38%
pharmaceuticals
Algernon Pharmaceuticals Announces Increase to Private Placement
Published: 2023-12-27 (Crawled : 12:00) - globenewswire.com
AGNPF | $0.0716 178.69% 12K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
pharmaceuticals
Algernon Pharmaceuticals Announces Private Placement
Published: 2023-12-13 (Crawled : 01:00) - globenewswire.com
AGNPF | $0.0716 178.69% 12K
|
Health Technology
|
| O: 3.68%
H: 0.0%
C: -5.92%
pharmaceuticals
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD
Published: 2023-11-30 (Crawled : 17:00) - biospace.com/
AGNPF | $0.0716 178.69% 12K
|
Health Technology
|
| O: 12.32%
H: 0.0%
C: 0.0%
patent treat pharmaceuticals grant chinese nash
Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
Published: 2023-11-22 (Crawled : 12:00) - globenewswire.com
AGNPF | $0.0716 178.69% 12K
|
Health Technology
|
| O: 7.95%
H: 45.61%
C: 24.56%
acquisition pharmaceuticals research program
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Last 48 Hours Insiders Buying
MEGI | $11.975 1.87% 0.04% 140K
|
|
00:30
CTRN P 29000 | $22.25 0.14% 0.13% 100K
|
Retail Trade
|
22:00
CONN | $3.71 1.37% 1.35% 72K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.6897 39.71% 2.3K
|
Utilities
|
18:30
CMTV P 700 | $15.74 17.43% 12K
|
Finance and Insurance
|
18:30
FNB | $13.63 2.17% 0.0% 2.5M
|
Finance
|
17:30
RMCF | $3.57 0.28% 2.8K
|
Consumer Non-Durables
|
20:10